RBM10 and intrahepatic cholangiocarcinoma: The mutational landscape of RBM10 in solid tumors revealed high mutation rates in both extrahepatic cholangiocarcinoma (7.4%, 26/351) and intrahepatic cholangiocarcinoma (6.3%, 32/508) in the Chinese populations(Fig. 1.